The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Alexion Pharmaceuticals Inc

Nasdaq: ALXN(*E)
Last

(U.S.) $122.96

Today's change+0.95 +0.78%
Updated December 2 4:00 PM EST. Delayed by at least 15 minutes.
 

Alexion Pharmaceuticals Inc

Nasdaq: ALXN(*E)
Last

(U.S.) $122.96

Today's change+0.95 +0.78%
Updated December 2 4:00 PM EST. Delayed by at least 15 minutes.

Alexion Pharmaceuticals Inc crosses above 50-day moving average

Alexion Pharmaceuticals Inc closed up Friday by (U.S.)$0.95 or 0.78% to (U.S.)$122.96 and crossing above its 50-day moving average. Over the last five days, shares have gained 3.48%, but are down 35.54% for the last year to date. Shares have underperformed the S&P 500 by 35.77% during the last year.

Key company metrics

  • Open(U.S.) $122.50
  • Previous close(U.S.) $122.01
  • High(U.S.) $123.45
  • Low(U.S.) $121.34
  • Bid / Ask(U.S.) $113.52 / (U.S.) $122.90
  • YTD % change-35.54%
  • Volume1,251,394
  • Average volume (10-day)1,698,125
  • Average volume (1-month)3,000,304
  • Average volume (3-month)1,941,606
  • 52-week range(U.S.) $110.56 to (U.S.) $193.45
  • Beta1.41
  • Trailing P/E75.57×
  • P/E 1 year forward26.53×
  • Forward PEG1.46×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.63
Updated December 2 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue799753701701
Total other revenue--------
Total revenue799753701701
Gross profit728692642643
Total cost of revenue71615958
Total operating expense620558535604
Selling / general / administrative230232233242
Research & development196179167191
Depreciation / amortization82808980
Interest expense (income), net operating--------
Unusual expense (income)417-1333
Other operating expenses, total--------
Operating income17919516697
Interest income (expense), net non-operating-25---24-23
Gain (loss) on sale of assets--------
Other--------
Income before tax15817014475
Income after tax941159267
Income tax, total6455518
Net income941159267
Total adjustments to net income--------
Net income before extra. items941159267
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items941159267
Inc. avail. to common incl. extra. items941159267
Diluted net income951159267
Dilution adjustment1------
Diluted weighted average shares226226227228
Diluted EPS excluding extraordinary itemsvalue per share0.420.510.410.29
Dividends per sharevalue per share--0.000.00--
Diluted normalized EPSvalue per share0.530.530.370.42